Cabazitaxel STADA 20 mg/ ml Νορβηγία - Νορβηγικά - Statens legemiddelverk

cabazitaxel stada 20 mg/ ml

stada arzneimittel ag - kabazitaksel - konsentrat til infusjonsvæske, oppløsning - 20 mg/ ml

Jevtana 60 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

jevtana 60 mg

orifarm as - kabazitaksel - konsentrat og væske til infusjonsvæske, oppløsning - 60 mg

Cabazitaxel Accord Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

cabazitaxel accord

accord healthcare s.l.u. - cabazitaxel - prostatic neoplasmer, kastrering-resistant - antineoplastiske midler - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.

Jevtana Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

jevtana

sanofi winthrop industrie - cabazitaxel - prostata neoplasmer - antineoplastiske midler - jevtana i kombinasjon med prednison eller prednisolon er indisert for behandling av pasienter med hormon-ildfast metastatisk prostatakreft som tidligere er behandlet med en docetaxelholdig diett.

Sporanox 100 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

sporanox 100 mg

janssen-cilag as - itrakonazol - kapsel, hard - 100 mg

Xtandi Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Sporanox 100 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

sporanox 100 mg

2care4 aps - itrakonazol - kapsel, hard - 100 mg

Ketoconazole HRA Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

ketoconazole hra

hra pharma rare diseases - ketoconazole - cushing syndrome - antimykotika for systemisk bruk - ketokonazol hra er indisert for behandling av endogent cushings syndrom hos voksne og ungdom over 12 år.

Tafinlar Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

tafinlar

novartis europharm limited - dabrafenib mesilate - melanom - antineoplastiske midler - melanomadabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 og 5. adjuvant behandling av melanomadabrafenib i kombinasjon med trametinib er indikert for adjuvant behandling av voksne pasienter med stadium iii melanom med en braf v600 mutasjon, følgende komplett reseksjon. non-small cell lung cancer (nsclc)dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a braf v600 mutation.

Pacligen 6 mg/ ml Νορβηγία - Νορβηγικά - Statens legemiddelverk

pacligen 6 mg/ ml

sandoz - københavn - paklitaksel - konsentrat til infusjonsvæske, oppløsning - 6 mg/ ml